Man in bed suffering from insomnia and sleep disorder

(© Prostock-studio - stock.adobe.com)

Adults With Body Clock Depression Report Weaker Antidepressant Relief

In A Nutshell

  • Australian researchers propose a new type of depression tied to the body’s internal clock, found in nearly 1 in 4 of 11,380 adults studied.
  • People with it started having depression earlier, around age 19 instead of 23, and reported more intense symptoms.
  • They reported less relief and more side effects from two widely used types of antidepressants, SSRIs and SNRIs.
  • Researchers say light therapy and melatonin may help, but the study did not test them and the subtype still needs confirmation.

Some people with depression stay up late, sleep far longer than usual during bad stretches, and wake up exhausted. University of Sydney scientists say that pattern may mark a distinct type of depression, called a circadian subtype, tied to the body’s internal clock. It showed up in nearly 1 in 4 adults with severe, recurring depression in their Australian study. People with it also reported less relief from two widely used types of antidepressants, and the researchers argue that light therapy and melatonin deserve a much earlier look.

Published in The British Journal of Psychiatry, the study drew on survey and genetic data from 11,380 adults. People in the circadian group started having depression earlier, around age 19 instead of 23, and reported more intense symptoms, including suicidal thoughts and manic-like experiences. More than half had gone through ten or more episodes, compared with just over a third of everyone else.

Co-senior author Jacob Crouse of the university’s Brain and Mind Centre said treatments targeting the circadian rhythm, such as light therapy and melatonin, “may be much more relevant” for these patients. Those treatments were not tested in the study, and the authors call their findings “an initial exploration.”

Circadian Subtype of Depression Appeared in 23 Percent of 11,380 Adults

Data came from the Australian Genetics of Depression Study, a nationwide project that enrolled adults diagnosed with depression at some point in their lives. Participants were recruited through government prescription records or a public media campaign. The adults in this analysis were of genetically inferred European ancestry, about three-quarters were women, and the average age was roughly 44. Across the full study, the typical participant had been through six depressive episodes, and about two-thirds had experienced suicidal thoughts.

Participants filled out online surveys about their sleep, mood, and experiences with ten commonly prescribed antidepressants. Researchers then looked for six body clock traits: sleep schedules that swing between work days and days off, moods that shift with the seasons, unusually late sleep timing, strong night-owl tendencies, heavy tiredness right after waking, and sleeping much more than normal during depressive episodes. Anyone with at least three landed in the circadian group, which came to 2,604 people, or 23 percent of the sample.

Depression and the Body Clock Infographic
Scientists propose a new type of depression tied to the body clock, found in nearly 1 in 4 adults in a large Australian study. (Image by StudyFinds)

Circadian Subtype of Depression Linked to Higher Genetic Risk and More Distress

Compared with everyone else, the circadian group was younger (about 38 versus 46 on average) and more often female (80 versus 73 percent). Members also reported more psychological distress, unusual perceptions or beliefs, and bodily complaints.

DNA told a similar story. Researchers tallied how many gene variants each person carried that are linked to certain traits and conditions. The circadian group carried somewhat more of those tied to depression, ADHD, anxiety, bipolar disorder, insomnia, and body weight, though the differences were small. The strongest link of all was to variants tied to being a night owl. Those patterns hint that these symptoms reflect more than overlapping sleep problems, though independent research must confirm whether they point to a biologically distinct form of depression.

Circadian Subtype of Depression Tied to Weaker Antidepressant Relief

Participants rated how well each antidepressant had worked for them. The circadian group reported less relief from two of the most widely used types, SSRIs and SNRIs, which work on serotonin and related brain chemicals, and more side effects such as drowsiness, muscle pain, nausea, and anxiety. The gaps were modest, and two other drugs, amitriptyline and mirtazapine, showed no clear difference.

One explanation the authors float is that standard medications, which act on brain chemicals, may not do enough to correct a body clock running off schedule. Authors say clock-focused approaches, including dimmer evenings and regular sleep and wake times, may benefit people with depression and disrupted sleep rhythms.

Ian Hickie, Co-Director of the Brain and Mind Centre, said that missing this pattern in young people often leads to early treatment failures and more side effects, and that most young people are offered SSRIs first. First author Emiliana Tonini put the broader point simply: “Depression is not a uniform illness.”

Today, treatment guidelines mostly sort depression by how severe it is or how often it returns, not by what is driving it, which often sends patients through rounds of trial and error with medication. A subtype tied to the body clock could point some of them toward different options sooner.

Because those ratings came from memory at one point in time, the study cannot show that a disrupted body clock causes the weaker response. It also enrolled only adults, so findings in teenagers remain untested. Results do not mean everyone who struggles with antidepressants has a body clock problem.

Confirming that the group is real is the next job. Until then, the finding describes one Australian sample made up largely of severe, recurring cases, not depression as a whole.


Disclaimer: This article is based on a published research paper and a university press release and is intended for general informational purposes only. It is not medical advice. Anyone struggling with depression or with their current medication should talk with a qualified health professional before making any changes to treatment.


Paper Notes

Limitations

Researchers relied on self-reported surveys, which can introduce recall bias, and the circadian traits did not directly measure internal body clock markers such as the timing or strength of daily rhythms. The design was cross-sectional, a single snapshot in time, so it cannot establish cause and effect. Antidepressant ratings reflect participants’ own recollections, and the ten drugs were grouped into broader classes, which may have masked differences between individual medications. The sample was limited to people of genetically inferred European ancestry, which may limit how well the results apply to other populations. Most circadian traits were meant to capture long-standing patterns, while sleeping more than usual was assessed during the worst depressive episode. The authors described the criteria as exploratory, noting that all six traits were weighted equally, no prespecified cutoffs were applied, and replication in independent samples is needed. Some genetic and treatment findings also weakened when participants who did not meet depression criteria were excluded. Light therapy, melatonin, and other body clock treatments were not tested. The paper proposes them as possibilities, and the stronger statements about them come from researcher comments in a University of Sydney press release.

Funding and Disclosures

Primary funding for the Australian Genetics of Depression Study came from grant 1086683 from the National Health and Medical Research Council of Australia. Additional support came from philanthropic donations by families affected by mental illness, investigator grants from the same council, and a Wellcome Trust Mental Health Award. Author Ian B. Hickie is Co-Director of Health and Policy at the Brain and Mind Centre at the University of Sydney, which operates early intervention youth services under contract to headspace. He has previously led community-based and pharmaceutical industry-supported projects (Wyeth, Eli Lilly, Servier, Pfizer, AstraZeneca, Janssen Cilag) and is Chief Scientific Advisor to, and a 3.2% equity shareholder in, InnoWell Pty Ltd. The paper states that no artificial intelligence tools were used in the research or writing process.

Publication Details

This article is based on the paper “Clinical and genetic correlates of a circadian subtype of depression in the Australian Genetics of Depression Study,” published in The British Journal of Psychiatry (2026), pages 1 to 10, by Cambridge University Press on behalf of the Royal College of Psychiatrists, under an open access Creative Commons Attribution license. DOI: 10.1192/bjp.2026.10798. The paper was received March 4, 2026, and accepted August 12, 2026. Emiliana Tonini is the first author and corresponding author ([email protected]). Jacob J. Crouse and Ian B. Hickie contributed equally, and the press release describes Crouse as co-senior author. Quotes from Jacob Crouse and Emiliana Tonini, and Ian Hickie’s comments on young people, come from the University of Sydney press release titled “Researchers identify new ‘circadian’ subtype of depression.” Full author list: Emiliana Tonini, Jacob J. Crouse, Mirim Shin, Joanne S. Carpenter, Brittany L. Mitchell, Enda M. Byrne, Penelope A. Lind, Scott D. Gordon, Richard Parker, Samuel J. Hockey, Timothy To, Andrew Shim, Alex Hill, Anna Treneman, Elizabeth Scott, Jan Scott, Kathleen R. Merikangas, Naomi R. Wray, Nicholas G. Martin, Sarah E. Medland, and Ian B. Hickie. Affiliations include the Brain and Mind Centre at the University of Sydney, QIMR Berghofer Medical Research Institute, the University of Queensland, Queensland University of Technology, Newcastle University, the National Institute of Mental Health, and the University of Oxford.

About StudyFinds Analysis

Called "brilliant," "fantastic," and "spot on" by scientists and researchers, our acclaimed StudyFinds Analysis articles are created using an exclusive AI-based model with complete human oversight by the StudyFinds Editorial Team. For these articles, we use an unparalleled LLM process across multiple systems to analyze entire journal papers, extract data, and create accurate, accessible content. Our writing and editing team proofreads and polishes each and every article before publishing. With recent studies showing that artificial intelligence can interpret scientific research as well as (or even better) than field experts and specialists, StudyFinds was among the earliest to adopt and test this technology before approving its widespread use on our site. We stand by our practice and continuously update our processes to ensure the very highest level of accuracy. Read our AI Policy (link below) for more information.

Our Editorial Process

StudyFinds publishes digestible, agenda-free, transparent research summaries that are intended to inform the reader as well as stir civil, educated debate. We do not agree nor disagree with any of the studies we post, rather, we encourage our readers to debate the veracity of the findings themselves. All articles published on StudyFinds are vetted by our editors prior to publication and include links back to the source or corresponding journal article, if possible.

Our Editorial Team

Steve Fink

Editor-in-Chief

John Anderer

Associate Editor